Drugs / rBBX-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00869388 | Oct 2008 → Nov 2009 | cancer | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rBBX-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00869388 ↗ |
| Route | Subcutaneous | “rBBX-01 1.0 mg/m2 SC on 5 consecutive days on weeks 1, 3, 5, and 7” NCT00869388 ↗ |